The Role Of MRI In The Cervical Cancer Staging And Detection Of Recrudescence And Failure In The Treatment Of Cervical Cancer

Objective: To explore the feasibility of staging cervical cancer by MRI and evaluate the role of MRI in the detection of recurrent cervical carcinoma. Methods: This study analyzed 78 cases of cervical cancer patients which were treated at the affiliated Hospital of Medical College, aged 29 to 85 years, median age 45 years. The average age is 47.8 years. The 40 sufferers in earlier period and the interim temple neck cancer go surgical operation treatment, 38 interim and later period sufferers don't go surgical operation treatments. Before treatment, all patients were confirmed by biopsy of cervical cancer. All patients have complete and detailed imaging results and pathological findings. And all patients'MRI features of cervical cancer have been analyzed and recorded according to the standard FIGO staging. This study Compare the Pathological staging with the FIGO staging and the MRI staging to evaluate MRI staging of cervical cancer. Between Mar. 2006 and Mar. 2006, 54patients undergone MRI to evaluate for cervical cancer recurrence at the affiliated Hospital of Medical College were reviewed. MRI findings were compared to available clinical data to classify each MRI result as a true positive, true negative, false positive, or false negative .Results: To pathologic staging as the standard FIGO staging accuracy rate is only 50% (20/40), MR staging accuracy was 77.5% (31/40). MRI staging have an advantage over FIGO in the early and middle stages staging. 40% of 40 cases of surgical patients'MR staging Coincide with the clinical stage. 71.05% of 38 cases of Radiotherapy patients'MR staging Coincide with the clinical stage.Conclusions: MRI is beneficial for us to select proper treatment for patients with cervical cancer. MRI is a sensitive and specific imaging modality for the detection of recurrent cervical cancer.